末梢血管デバイス市場：製品タイプ、技術タイプ、材料タイプ、適応症、患者タイプ、エンドユーザー別-2025-2030年世界予測

末梢血管デバイス市場の2023年の市場規模は139億米ドルで、2024年には146億6,000万米ドルに成長し、CAGRは5.95%、2030年には208億5,000万米ドルに達すると予測されています。

末梢血管機器市場は、慢性疾患の増加と低侵襲治療への需要の高まりという重圧の下で進化を続ける現代ヘルスケアにおける重要なセグメントです。この市場では、技術革新が患者の転帰を改善するだけでなく、ヘルスケアプロバイダーの業務効率とコスト削減を促進します。今日、技術進歩の急速なペースと、臨床医や患者のダイナミックなニーズとが相まって、末梢血管用デバイスは極めて重要な分野として位置づけられています。

ステントからグラフトまで幅広いこれらの器具は、卓越したエンジニアリングと医療ニーズの交差点を具現化するもので、複雑な血管の状態に高い精度で対処する機会を生み出しています。進化するヘルスケアの情勢は、規制状況の変化、血管疾患に対する科学的理解の深化、侵襲の少ない治療法への揺るぎないシフトによって特徴づけられます。デジタルヘルスと高度な製造技術がこの分野に統合されるにつれて、末梢血管用デバイスの役割は、世界中の心血管治療の成功にとってさらに中心的なものとなっています。

本サマリーは、市場の現状だけでなく、変革的な動向、セグメンテーションの洞察、地域のダイナミクス、主要企業の活動、将来の成長に向けた実行可能な提言に焦点を当てた包括的な概要を提供するものです。本書は、意思決定者、投資家、ヘルスケア専門家が、急速に変化する環境におけるこの市場の可能性のニュアンスを把握するのに役立ちます。

末梢血管デバイス市場の変革

過去10年間、末梢血管機器市場は、技術、規制、人口動態によって一連の変革期を迎えてきました。最も大きな変化の一つは、従来の開腹手術から低侵襲手術への移行です。これらの治療法は回復時間を短縮するだけでなく、より侵襲的な介入に伴うリスクを最小限に抑えることで、患者の満足度を向上させ、外来治療の幅を広げています。

技術の進歩は、より高度な制御と精度を提供する革新的な機器を導入することで、市場を再形成してきました。こうした開発により、例えばエンジニアは柔軟性と耐久性を向上させたステントやガイドワイヤーを設計できるようになり、また体内の生理学的変化に対応できるスマート素材も活用できるようになりました。メーカー各社は現在、データ分析とリアルタイムの画像処理機能を機器設計に組み込むことに注力しており、このシフトは継続的に効率を高め、安全性の成果を向上させています。

さらに、この市場では、個別化されたヘルスケアソリューションが重視されるようになっています。高度な画像処理モダリティと精密工学の結果として生み出された患者固有の医療機器は、現在ではこれまで以上に実現可能なものとなっています。規制改革は、これらの機器が厳格な安全・性能基準を遵守することを保証しながら、市場投入までの時間を短縮することを促進しました。レガシー製品の淘汰が進み、革新的で患者に合わせた治療法が求められる中、末梢血管への応用における精密医療への動向は必然であり、歓迎すべきことでもあります。

このような市場力学は、技術力と進化する臨床実践の融合に影響され、治療結果の向上だけでなく、より競争の激しい世界市場にもつながっています。手技リスクの軽減、製造プロセスの合理化、臨床成績の向上が相まって、この分野の持続的成長と投資に道が開かれつつあります。

末梢血管機器における主要セグメント洞察

末梢血管機器市場を徹底的に分析すると、様々なレベルでのビジネスチャンスをより深く理解するための高度に細分化された構造が明らかになります。市場は、製品タイプ、技術、材料、適応症、患者プロファイル、エンドユーザーに基づいて分解されます。製品セグメントに関しては、バルーン膨張装置、カテーテル、グラフト、ガイドワイヤー、下大静脈フィルター、イントロデューサー、プラーク修正装置、ステント、血管閉鎖装置が含まれます。特徴的なのは、カテーテルのカテゴリーが、長い末梢静脈内カテーテル、正中線カテーテル、短い末梢静脈内カテーテルに区別されることで、さらに細分化され、さまざまな臨床現場における治療のニュアンスの違いを際立たせていることです。同様に、グラフトは生物学的グラフト、ePTFEグラフト、ポリエステルグラフトに細分化され、ステントはさらにバルーン拡張型ステントと自己拡張型ステントに細分化されます。

技術の種類を考慮すると、市場は低侵襲手術と開腹手術に等分されます。低侵襲手術は血管形成術とステント留置術に分類され、手術リスクの低減と患者の回復時間の短縮により、インターベンションの大部分を占めています。対照的に、バイパス手術と内膜剥離術に分類される開腹手術は、侵襲性の低いアプローチでは十分でないような複雑なシナリオに不可欠です。

材料構成分析によると、市場は金属製と非金属製に大別されます。金属製器具は、その頑丈さと複雑な血管構造に適合する能力から、コバルトクロム、ニチノール、ステンレス鋼のような物質を特徴とすることが多いが、非金属製ソリューションでは、柔軟性と身体組織との適合性を重視するポリマーやシリコーン材料が利用されています。このような細分化は、材料科学の革新がいかに器具の機能性と耐久性に結びついているかを示しています。

さらに、適応症を調べると、機能性末梢血管疾患と閉塞性末梢血管疾患という2つの大きなカテゴリーがあることがわかる。機能性疾患には、慢性静脈不全、レイノー病、静脈瘤などの疾患が含まれ、一貫した快適な血管サポートを保証する器具が必要とされます。一方、アテローム性動脈硬化症、バージャー病、頸動脈疾患、深部静脈血栓症、リンパ浮腫などの閉塞性疾患では、機器の有効性が患者の予後に直接影響するため、より積極的な介入戦略が必要となります。

患者の属性は、成人・老年人口と小児人口に分類することでセグメンテーションをさらに充実させる。前者は急性および慢性疾患であり、長期的な健康管理において機器が重要な役割を果たします。小児患者の場合は、後天的なものであれ先天性のものであれ、若年患者特有の生理的課題を考慮した特殊なデバイスが必要となります。最後に、エンドユーザー別の市場セグメンテーションでは、外来手術センター、診療所、病院などの流通チャネルが、それぞれ独自の需要パターンを生み出し、臨床のスペクトル全体にわたって機器の設計と使用に影響を与えていることが示されています。

これらの複雑に定義されたセグメンテーション層は、利害関係者が新たな機会をピンポイントで特定し、製品イノベーションを調整し、最適な市場浸透のための標的戦略を考案することを可能にする貴重な洞察を提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 末梢血管疾患の罹患率の増加
    • 低侵襲治療オプションへの関心の高まり
  • 抑制要因
    • 高コストと製品リコールに関連する末梢血管デバイス
  • 機会
    • 末梢血管デバイスの進歩
    • ヘルスケアインフラへの政府の支援と投資
  • 課題
    • 医療機器の承認と廃棄に関する厳格な規制
• 市場セグメンテーション分析
  • 製品：長期治療投与用カテーテルの使用増加
  • 技術タイプ：患者の早期回復とトラウマ体験の軽減を求める声に応えて、低侵襲手術が急速に導入されている
  • 材料タイプ：優れた生体適合性と血栓形成の低減を実現する非金属デバイスの急速な利用
  • 適応症：生命維持に不可欠な介入を必要とする閉塞性末梢血管疾患（OPVD）に対する末梢血管デバイスの使用法の進化
  • 患者タイプ：成人患者における末梢血管デバイスの重要な応用
  • エンドユーザー：病院環境全体で末梢血管デバイスの用途を拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 末梢血管デバイス市場：製品別

• バルーン膨張装置
• カテーテル
  • 長い末梢静脈カテーテル
  • 正中線カテーテル
  • 短末梢静脈カテーテル
• 移植
  • 生物学的移植
  • ePTFEグラフト
  • ポリエステルグラフト
• ガイドワイヤー
• 下大静脈フィルター
• 紹介者
• プラーク修正デバイス
• ステント
  • バルーン拡張型ステント
  • 自己拡張型ステント
• 血管閉鎖デバイス

第7章 末梢血管デバイス市場テクノロジーの種類別

• 低侵襲手術
  • 血管形成術
  • ステント留置術
• 開腹手術
  • バイパス手術
  • 動脈内膜切除術

第8章 末梢血管デバイス市場：素材タイプ別

• 金属デバイス
  • コバルトクロム
  • ニチノール
  • ステンレス鋼
• 非金属デバイス
  • ポリマー
  • シリコーン

第9章 末梢血管デバイス市場：適応症別

• 機能性末梢血管疾患
  • 慢性静脈不全
  • レイノー病
  • 静脈瘤
• 閉塞性末梢血管疾患
  • 動脈硬化症
  • バージャー病
  • 頸動脈疾患
  • 深部静脈血栓症
  • リンパ浮腫

第10章 末梢血管デバイス市場患者タイプ別

• 成人および高齢者
  • 急性疾患
  • 慢性疾患
• 小児科
  • 後天性疾患
  • 先天性疾患

第11章 末梢血管デバイス市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第12章 南北アメリカの末梢血管デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の末梢血管デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの末梢血管デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AMECATH
• AngioDynamics, Inc.
• Argon Medical Devices, Inc.
• ASAHI INTECC CO., LTD
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group Incorporated
• Cordis
• Esaote S.p.A.
• FUJIFILM Holdings Corporation
• GE HealthCare
• Kimal PLC
• Koninklijke Philips N.V.
• Lepu Medical Technology（Beijing）Co., Ltd.
• Medtronic PLC
• Merit Medical Systems, Inc.
• Nipro Corporation
• Penumbra, Inc.
• Sahajanand Medical Technologies Limited
• Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
• Siemens Healthineers AG
• Summa Therapeutics, LLC
• Teleflex Incorporated
• Terumo Corporation
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. PERIPHERAL VASCULAR DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. PERIPHERAL VASCULAR DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. PERIPHERAL VASCULAR DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PERIPHERAL VASCULAR DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 67. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 68. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 69. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 71. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 72. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 79. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 80. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 85. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 86. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 87. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 88. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 89. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 91. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 93. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 94. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 95. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 97. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 98. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 100. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 101. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 104. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 105. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 106. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 107. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 110. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 111. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 112. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 114. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 115. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 120. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 121. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 122. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 123. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 124. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 127. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 128. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 129. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 131. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 132. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 137. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 138. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 139. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 140. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 141. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 144. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 145. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 146. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 148. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 149. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 150. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 154. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 155. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 156. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 157. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 158. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 161. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 162. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 163. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 165. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 166. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 167. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 171. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 172. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 173. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 174. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 175. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 177. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 179. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 180. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 181. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 183. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 184. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 185. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 186. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 189. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 190. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 191. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 192. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 193. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 195. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 197. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 198. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 199. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 201. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 202. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 203. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 207. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 208. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 209. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 210. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 211. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 214. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 215. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 216. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 218. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 219. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 220. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 221. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 222. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 223. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 224. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 225. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 226. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 227. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 228. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 231. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 232. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 233. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 235. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 236. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 237. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 239. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 240. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 241. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 242. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 243. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 244. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 245. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 248. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 249. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 250. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 251. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 252. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 253. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 254. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 257. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 258. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 259. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 260. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 261. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 262. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 265. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 266. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 267. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 269. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 270. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 271. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 272. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 273. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 274. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 275. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 276. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 277. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 278. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 279. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 280. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 281. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 282. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 283. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 284. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 285. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 286. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 287. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 288. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 289. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 290. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 291. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 292. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 293. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
• TABLE 294. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 295. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
• TABLE 296. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 298. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 299. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2030 (USD MILLION)
• TABLE 300. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 301. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
• TABLE 302. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2030 (USD MILLION)
• TABLE 303. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
• TABLE 304. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 305. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 306. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 307. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 308. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 309. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2030 (USD MILLION)
• TABLE 310. PHILIPPINES PERIPHERAL VASCULAR DEVI

The Peripheral Vascular Devices Market was valued at USD 13.90 billion in 2023 and is projected to grow to USD 14.66 billion in 2024, with a CAGR of 5.95%, reaching USD 20.85 billion by 2030.

The peripheral vascular devices market represents a critical segment in modern healthcare that continues to evolve under the pressure of rising chronic diseases and the increasing demand for minimally invasive therapies. In this market, innovation drives not only improved patient outcomes but also operational efficiencies and cost reductions for healthcare providers. Today, the rapid pace of technological advancement combined with the dynamic needs of clinicians and patients has positioned peripheral vascular devices as a pivotal area of focus.

These devices, which range from stents to grafts, embody the intersection of engineering excellence and medical needs, creating opportunities to address complex vascular conditions with enhanced precision. The evolving healthcare landscape is marked by shifting regulatory standards, deeper scientific understanding of vascular conditions, and an unwavering shift towards less invasive treatment options. As digital health and advanced manufacturing techniques integrate into this space, the role of peripheral vascular devices becomes even more central to the success of cardiovascular interventions around the globe.

This summary serves to provide a comprehensive overview that highlights not only the market's current state but also the transformative trends, segmentation insights, regional dynamics, leading company activities, and actionable recommendations for future growth. The narrative that follows will help decision-makers, investors, and healthcare experts grasp the nuances of this market's potential in a rapidly changing environment.

Transformative Shifts in the Peripheral Vascular Devices Landscape

Over the past decade, the peripheral vascular devices market has undergone a series of transformative shifts driven by technology, regulation, and demographics. One of the most significant changes has been the transition from traditional open surgeries to minimally invasive procedures. These procedures not only reduce recovery times but also minimize the risks associated with more invasive interventions, thereby improving patient satisfaction and widening the scope for outpatient treatments.

Technological advancements have reshaped the market by introducing innovative devices that offer enhanced control and precision. These developments have, for example, enabled engineers to design stents and guidewires with improved flexibility and durability while also leveraging smart materials that can respond to physiological changes within the body. Manufacturers now focus on integrating data analytics and real-time imaging capabilities into device design, a shift that is continuously driving efficiency and improving safety outcomes.

Additionally, the market has seen an increased emphasis on personalized healthcare solutions. Patient-specific devices, created as a result of advanced imaging modalities and precision engineering, are now more attainable than ever. Regulatory reforms have facilitated a faster time-to-market while ensuring that these devices adhere to stringent safety and performance standards. With the brown field of legacy products making way for innovative, patient-tailored therapies, the trend towards precision medicine in peripheral vascular applications is both inevitable and welcome.

These market dynamics, influenced by the convergence of technological prowess and evolving clinical practices, have led not only to enhanced therapeutic outcomes but also to a more competitive global marketplace. The combination of reduced procedural risks, streamlined manufacturing processes, and improved clinical results is paving the way for sustained growth and investment in the sector.

Key Segmentation Insights in Peripheral Vascular Devices

A thorough appraisal of the peripheral vascular devices market reveals a highly segmented structure that facilitates a deeper understanding of the opportunities at various levels. The market is dissected based on product type, technology, material, indication, patient profile, and end-user. Regarding product segmentation, the domain encompasses balloon inflation devices, catheters, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure devices. Distinctively, the catheter category experiences further granularity by distinguishing long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters, highlighting the variations in treatment nuances across different clinical settings. Similarly, grafts subdivide into biological grafts, ePTFE grafts, and polyester grafts, while stents further divide into balloon-expandable stents and self-expanding stents.

When considering technology type, the market equally splits between minimally invasive surgeries and open surgeries. Minimally invasive procedures are further examined under the banners of angioplasty and stenting, which collectively represent a significant portion of the interventions due to their reduced operative risk and quicker patient recovery times. In contrast, open surgery, categorized into bypass surgery and endarterectomy, remains indispensable for complex scenarios where less invasive approaches may not suffice.

Material composition analysis shows that the market is bracketed by metal and non-metal devices. Metal devices often feature substances like cobalt chromium, nitinol, and stainless steel because of their robustness and an ability to conform to intricate vascular structures, while non-metal solutions utilize polymer and silicone materials that emphasize flexibility and compatibility with bodily tissues. Such segmentation demonstrates how material science innovations translate into device functionality and durability.

Furthermore, an examination of indications reveals two broad categories: functional and occlusive peripheral vascular diseases. Functional conditions, which include ailments such as chronic venous insufficiency, Raynaud's disease, and varicose veins, demand devices that ensure consistent and comfortable vascular support. On the other hand, occlusive conditions like atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema require a more aggressive intervention strategy where device efficacy can directly influence patient prognosis.

Patient demographics further enrich segmentation with classifications into adult & geriatric and pediatric populations. The former is signified by acute and chronic conditions where devices play a crucial role in managing long-term health. Pediatric cases, whether stemming from acquired or congenital conditions, demand specialized device considerations given the unique physiological challenges of younger patients. Finally, the market segmentation by end-user demonstrates that the distribution channels include ambulatory surgical centers, clinics, and hospitals, each creating unique demand patterns and influencing the design and usage of devices across the spectrum of clinical practice.

These intricately defined segmentation layers provide valuable insights that enable stakeholders to pinpoint emerging opportunities, tailor product innovations, and devise targeted strategies for optimal market penetration.

Based on Product, market is studied across Balloon Inflation Devices, Catheters, Grafts, Guidewires, Inferior Vena Cava Filters, Introducers, Plaque Modification Devices, Stents, and Vascular Closure Devices. The Catheters is further studied across Long Peripheral Intravenous Catheters, Midline Catheters, and Short Peripheral Intravenous Catheter. The Grafts is further studied across Biological Grafts, ePTFE Grafts, and Polyester Grafts. The Stents is further studied across Balloon-Expandable Stents and Self-Expanding Stents.

Based on Technology Type, market is studied across Minimally Invasive Surgeries and Open Surgery. The Minimally Invasive Surgeries is further studied across Angioplasty and Stenting. The Open Surgery is further studied across Bypass Surgery and Endarterectomy.

Based on Material Type, market is studied across Metal Devices and Non-Metal Devices. The Metal Devices is further studied across Cobalt Chromium, Nitinol, and Stainless Steel. The Non-Metal Devices is further studied across Polymer and Silicone.

Based on Indication, market is studied across Functional Peripheral Vascular Disease and Occlusive Peripheral Vascular Disease. The Functional Peripheral Vascular Disease is further studied across Chronic Venous Insufficiency, Raynaud's Disease, and Varicose Veins. The Occlusive Peripheral Vascular Disease is further studied across Atherosclerosis, Buerger's Disease, Carotid Artery Disease, Deep Vein Thrombosis, and Lymphedema.

Based on Patient Types, market is studied across Adult & Geriatric and Pediatric. The Adult & Geriatric is further studied across Acute Conditions and Chronic Conditions. The Pediatric is further studied across Acquired Conditions and Congenital Conditions.

Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.

Regional Insights Shaping Market Opportunities

The geographic landscape of the peripheral vascular devices market is characterized by diverse regional trends that mirror distinct healthcare infrastructures and economic conditions. In the Americas, robust healthcare expenditure combined with advanced technological adoption drives market growth, where the integration of advanced devices in routine clinical practice is routinely observed. The region benefits from established regulatory frameworks that support innovation and create a conducive environment for research and development.

In Europe, the Middle East & Africa, healthcare systems are equally attuned to the benefits of state-of-the-art vascular interventions. This region experiences a blend of mature markets in Western Europe, emerging markets in Africa, and dynamic growth pockets in the Middle East. Variations in healthcare policies and reimbursement scenarios have resulted in a landscape where strategic partnerships and collaborations are vital to drive device adoption. Innovations in device manufacturing, particularly in terms of miniaturization and improved material properties, are notably well-received, further fostering market expansion in these areas.

Asia-Pacific stands at the forefront of market dynamism, driven by rapid urbanization, increasing healthcare awareness, and a surge in government initiatives aimed at improving healthcare infrastructure. The region's large population base coupled with rising disposable incomes ensures a significant demand for cutting-edge peripheral vascular devices. The market in Asia-Pacific is marked by an accelerating shift towards minimally invasive procedures as state-of-the-art surgical techniques become the norm in leading hospitals and urban clinics. Collectively, these regional insights underscore the importance of tailored strategies that take into account the unique economic and regulatory conditions inherent to each market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Leading the Peripheral Vascular Devices Sector

A closer examination of the competitive landscape reveals several key players that command significant influence over the peripheral vascular devices market. Market pioneers such as Abbott Laboratories and AMECATH have established robust portfolios that underscore their commitment to innovative solutions. Companies like AngioDynamics, Inc. and Argon Medical Devices, Inc. are known for their emphasis on research and development, ensuring that their products continuously integrate the latest technological advancements.

American industry leaders such as ASAHI INTECC CO., LTD demonstrate a high level of precision in device engineering, while firms like B. Braun SE and Baxter International Inc. continue to build on longstanding legacies of reliability and performance. Traditional industry stalwarts, including Becton, Dickinson and Company and BIOTRONIK SE & Co. KG, leverage a history of clinical excellence to bolster their market positions. Meanwhile, companies such as Boston Scientific Corporation and Cardinal Health, Inc. deliver comprehensive solutions that holistically address vascular challenges.

Cook Group Incorporated and Cordis further contribute to a competitive market environment with their innovative technology platforms that are reaping remarkable clinical benefits. Esaote S.p.A. and FUJIFILM Holdings Corporation have also made significant advances, integrating digital diagnostic capabilities with interventional device technologies. Industry leaders like GE HealthCare and Kimal PLC remain at the forefront of research and design, while Koninklijke Philips N.V. and Lepu Medical Technology (Beijing) Co., Ltd. continue to push the envelope in imaging and device synergy. Medtronic PLC and Merit Medical Systems, Inc. are prominent examples of companies that have built deep, diversified portfolios to meet a wide range of clinical needs.

Furthermore, the competitive landscape is buoyed by the contributions of Nipro Corporation, Penumbra, Inc., Sahajanand Medical Technologies Limited, and Shockwave Medical, Inc. by Johnson & Johnson Services, Inc. Their efforts in combining engineering precision with clinical insight underscore the sector's focus on outcome-based solutions. Siemens Healthineers AG, Summa Therapeutics, LLC, Teleflex Incorporated, Terumo Corporation, and W. L. Gore & Associates, Inc. round out a market populated by the most capable and innovative entities. The cumulative effect of this competitive environment is a continuous push for quality, cost-effectiveness, and technological advancement across the entire market.

The report delves into recent significant developments in the Peripheral Vascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMECATH, AngioDynamics, Inc., Argon Medical Devices, Inc., ASAHI INTECC CO., LTD, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Cordis, Esaote S.p.A., FUJIFILM Holdings Corporation, GE HealthCare, Kimal PLC, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra, Inc., Sahajanand Medical Technologies Limited, Shockwave Medical, Inc. by Johnson & Johnson Services, Inc., Siemens Healthineers AG, Summa Therapeutics, LLC, Teleflex Incorporated, Terumo Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Industry Leaders

Decision-makers in the peripheral vascular devices market should capitalize on existing opportunities while preparing strategically for future challenges. One of the foremost recommendations is to invest heavily in research and development to continue driving innovative breakthroughs, particularly in the areas of minimally invasive surgery and personalized device design. It is vital to integrate advanced materials and incorporate digital health technologies that can provide real-time data to inform procedural improvements. Fostering partnerships between academia, clinical research centers, and manufacturers can help streamline the adoption of cutting-edge technologies.

Leaders should also consider diversifying product portfolios to include both metal and non-metal device options, ensuring that the range of products stays relevant across diverse patient profiles and complex vascular conditions. Moreover, adopting a segmentation-focused approach can serve companies well by allowing for precise targeting of treatments based on patient type and disease indication. By closely monitoring market segmentation trends and consumer behavior, companies can adjust their strategies to better cater to the distinct needs of adult, geriatric, and pediatric patient groups.

Expanding geographic footprint remains an essential tactic as well. Firms should leverage emerging markets in Asia-Pacific and regions with robust growth potential such as parts of Europe and the Middle East & Africa. This geographic diversification not only mitigates risk but also exposes companies to a wider array of opportunities, thereby ensuring sustained revenue growth.

Furthermore, industry leaders are encouraged to focus on operational excellence by optimizing supply chains and reinforcing quality assurance protocols. In an era where both regulatory demands and patient expectations are intensifying, aligning internal processes with global standards is paramount. Companies must balance innovation with precision in execution to ensure that high-quality products are accessible, economically feasible, and clinically effective.

Finally, proactive engagement with regulators and policy makers can help shape a favorable operating environment that encourages innovation while safeguarding patient health. Such collaboration is essential for accelerating device approvals and facilitating smoother market entry processes for next-generation products.

Conclusion: The Road Ahead in Peripheral Vascular Devices

In summary, the peripheral vascular devices market is poised for a new era marked by technological innovation, refined segmentation strategies, and expansive regional growth. The shift towards minimally invasive procedures and precision medicine has fundamentally redefined therapeutic strategies, ensuring that patient outcomes are continually improved. This evolution is supported by a wide array of product offerings, differentiated by material, indication, technology, and patient type, which together create a versatile and resilient market ecosystem.

The competitive landscape is vibrant, driven by leading companies that are steadfast in their commitment to clinical excellence and innovation. Such players continually refine their strategies and portfolios in response to emerging trends, thereby fostering a climate of healthy competition and sustainable growth. By aligning research, investment, and operational practices, the industry is well-prepared to address the evolving challenges of healthcare delivery on a global scale.

Looking forward, a collaborative approach that bridges clinical expertise, regulatory alignment, and technological advancement will be critical to unlocking the full potential of the peripheral vascular devices market. As the industry navigates an increasingly complex and competitive landscape, the convergence of these factors will define the future of vascular treatment modalities and drive long-term market sustainability.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. The increasing prevalence of peripheral vascular diseases
    • 5.1.1.2. Rising preference for minimally invasive treatment options
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and product recalls associated peripheral vascular devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing advancement in the peripheral vascular devices
    • 5.1.3.2. Governmental support and investment in healthcare infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations for approval and disposal of medical devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Proliferating usage of the catheters for prolonged therapy administration
  • 5.2.2. Technology Type: Rapid adoption of minimally invasive procedures fueled by patient demand for quicker recoveries and less traumatic experiences
  • 5.2.3. Material Type: Burgeoning utilization of non-metal devices providing superior biocompatibility and reduced thrombus formation
  • 5.2.4. Indication: Evolving usage of peripheral vascular devices for occlusive peripheral vascular disease (OPVD) driven by critical, life-preserving interventions
  • 5.2.5. Patient Types: Significant application of peripheral vascular devices the in adult patients
  • 5.2.6. End-User: Expanding applications of peripheral-vascular-devices across hospitals settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Peripheral Vascular Devices Market, by Product

• 6.1. Introduction
• 6.2. Balloon Inflation Devices
• 6.3. Catheters
  • 6.3.1. Long Peripheral Intravenous Catheters
  • 6.3.2. Midline Catheters
  • 6.3.3. Short Peripheral Intravenous Catheter
• 6.4. Grafts
  • 6.4.1. Biological Grafts
  • 6.4.2. ePTFE Grafts
  • 6.4.3. Polyester Grafts
• 6.5. Guidewires
• 6.6. Inferior Vena Cava Filters
• 6.7. Introducers
• 6.8. Plaque Modification Devices
• 6.9. Stents
  • 6.9.1. Balloon-Expandable Stents
  • 6.9.2. Self-Expanding Stents
• 6.10. Vascular Closure Devices

7. Peripheral Vascular Devices Market, by Technology Type

• 7.1. Introduction
• 7.2. Minimally Invasive Surgeries
  • 7.2.1. Angioplasty
  • 7.2.2. Stenting
• 7.3. Open Surgery
  • 7.3.1. Bypass Surgery
  • 7.3.2. Endarterectomy

8. Peripheral Vascular Devices Market, by Material Type

• 8.1. Introduction
• 8.2. Metal Devices
  • 8.2.1. Cobalt Chromium
  • 8.2.2. Nitinol
  • 8.2.3. Stainless Steel
• 8.3. Non-Metal Devices
  • 8.3.1. Polymer
  • 8.3.2. Silicone

9. Peripheral Vascular Devices Market, by Indication

• 9.1. Introduction
• 9.2. Functional Peripheral Vascular Disease
  • 9.2.1. Chronic Venous Insufficiency
  • 9.2.2. Raynaud's Disease
  • 9.2.3. Varicose Veins
• 9.3. Occlusive Peripheral Vascular Disease
  • 9.3.1. Atherosclerosis
  • 9.3.2. Buerger's Disease
  • 9.3.3. Carotid Artery Disease
  • 9.3.4. Deep Vein Thrombosis
  • 9.3.5. Lymphedema

10. Peripheral Vascular Devices Market, by Patient Types

• 10.1. Introduction
• 10.2. Adult & Geriatric
  • 10.2.1. Acute Conditions
  • 10.2.2. Chronic Conditions
• 10.3. Pediatric
  • 10.3.1. Acquired Conditions
  • 10.3.2. Congenital Conditions

11. Peripheral Vascular Devices Market, by End-User

• 11.1. Introduction
• 11.2. Ambulatory Surgical Centers
• 11.3. Clinics
• 11.4. Hospitals

12. Americas Peripheral Vascular Devices Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Peripheral Vascular Devices Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Peripheral Vascular Devices Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. AngioDynamics launches RECOVER-AV clinical trial to expand AlphaVac F1885 System usage in Europe
  • 15.3.2. Shockwave Medical's advanced catheter aims to redefine treatment landscape for complex peripheral artery disease
  • 15.3.3. Medtronic pioneers innovation in aortic procedures with the launch of Steerant aortic guidewire for endovascular aneurysm repair (EVAR) and thoracic EVAR (TEVAR)
  • 15.3.4. Philips unveils the Duo Venous Stent System revolutionizing treatment for venous outflow obstructions
  • 15.3.5. Abbott's revolutionary Esprit BTK dissolving stent sets a new standard in peripheral artery disease management
  • 15.3.6. AngioDynamics' AlphaVac F18 85 system gains FDA clearance, establishing a new standard in pulmonary embolism treatment strategies
  • 15.3.7. Strategic alliance between Zylox-Tonbridge and Avinger expands innovative OCT solutions in vascular interventions
  • 15.3.8. BD launches AGILITY study to assess innovative covered stent, aiming to expand peripheral arterial disease (PAD) treatment options worldwide
  • 15.3.9. Summa Therapeutics' Finesse catheter revolutionizes below-the-knee (BTK) angioplasty with innovative, multifunctional design
• 15.4. Strategy Analysis & Recommendation
  • 15.4.1. Abbott Laboratories
  • 15.4.2. Merit Medical Systems, Inc.
  • 15.4.3. Boston Scientific Corporation
  • 15.4.4. Medtronic PLC

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMECATH
• 3. AngioDynamics, Inc.
• 4. Argon Medical Devices, Inc.
• 5. ASAHI INTECC CO., LTD
• 6. B. Braun SE
• 7. Baxter International Inc.
• 8. Becton, Dickinson and Company
• 9. BIOTRONIK SE & Co. KG
• 10. Boston Scientific Corporation
• 11. Cardinal Health, Inc.
• 12. Cook Group Incorporated
• 13. Cordis
• 14. Esaote S.p.A.
• 15. FUJIFILM Holdings Corporation
• 16. GE HealthCare
• 17. Kimal PLC
• 18. Koninklijke Philips N.V.
• 19. Lepu Medical Technology (Beijing) Co., Ltd.
• 20. Medtronic PLC
• 21. Merit Medical Systems, Inc.
• 22. Nipro Corporation
• 23. Penumbra, Inc.
• 24. Sahajanand Medical Technologies Limited
• 25. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
• 26. Siemens Healthineers AG
• 27. Summa Therapeutics, LLC
• 28. Teleflex Incorporated
• 29. Terumo Corporation
• 30. W. L. Gore & Associates, Inc.